Summary
- Current Price
- As of today, MTNB price is $0.59, down -1.17% on
- Current Price All-Time High
- MTNB price is currently -99.70% below its historical high of $199.50 set on
- Market Cap
- MTNB current market cap is $4M, up +31.37% over the past 365 days
- PE Ratio
- MTNB PE ratio is unknown
- Revenue
- MTNB current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for MTNB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Matinas BioPharma Holdings, Inc. |
| Ticker | NYSEAmerican: MTNB |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | matinasbiopharma.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.59 | ||
| Price, 1D Change | -1.17% | |
| $4M | ||
| - | ||
| - | ||
| 0.50 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$4.98 | ||
| EPS, 1Y Change | +5.60% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.98 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.59 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.11 | -$5.28 | -4,699.55% | |
| -$4.06 | -$4.98 | -22.76% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.10M | $1.10M | 0.00% | |
| - | $0.00 | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +4.32% | ||
| -97.16% | ||
| +31.37% | ||
| -95.81% | ||
| -100.00% | ||
| -100.00% | ||
| +5.60% | ||
| +11.52% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.59 | ||
| $1.08 | ||
| SMA 200 vs Price | +83.63% | |
| $0.62 | ||
| SMA 50 vs Price | +5.68% | |
| 0.50 | ||
| $0.05 | ||
| 45.50 | ||
| 81.24% | ||
| 119.37% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.98 | ||
| -$972.00K | ||
| - | ||
| -$20.16M | ||
| - | ||
| -$24.25M | ||
| - | ||
| -$19.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.38 | ||
| 3.01 | ||
| 3.01 | ||
| - | ||
| - | ||
| -26.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.58 | ||
| -0.07 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $7.59M | ||
| $7.28M | ||
| $12.64M | ||
| $8.03M | ||
| $5.05M | ||
| $2.67M | ||
| $2.89M | ||
| $766.00K | ||
| $95.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $20.16M | ||
| $20.16M | ||
| $972.00K | ||
| $8.73M | ||
| $972.00K | ||
| $0.00 | ||
| -$80.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$15.89M | ||
| $9.21M | ||
| $9.17M | ||
| $0.00 | ||
| -$15.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| HC Wainwright & Co. | ||
| Aegis Capital | ||
| Piper Sandler | ||
| SunTrust Robinson Humphrey | ||
| HC Wainwright & Co. | ||
| H.C. Wainwright | ||
| BTIG Research | ||
| BTIG | ||
| Roth Capital |
Analyst sentiment
Institutional ownership
Screeners with MTNB
FAQ
What is the ticker symbol for Matinas BioPharma Holdings, Inc.?
The ticker symbol for Matinas BioPharma Holdings, Inc. is NYSEAmerican:MTNB
Does Matinas BioPharma Holdings, Inc. pay dividends?
No, Matinas BioPharma Holdings, Inc. does not pay dividends
What sector is Matinas BioPharma Holdings, Inc. in?
Matinas BioPharma Holdings, Inc. is in the Healthcare sector
What industry is Matinas BioPharma Holdings, Inc. in?
Matinas BioPharma Holdings, Inc. is in the Biotechnology industry
What country is Matinas BioPharma Holdings, Inc. based in?
Matinas BioPharma Holdings, Inc. is headquartered in United States
When did Matinas BioPharma Holdings, Inc. go public?
Matinas BioPharma Holdings, Inc. initial public offering (IPO) was on July 21, 2014
Is Matinas BioPharma Holdings, Inc. in the S&P 500?
No, Matinas BioPharma Holdings, Inc. is not included in the S&P 500 index
Is Matinas BioPharma Holdings, Inc. in the NASDAQ 100?
No, Matinas BioPharma Holdings, Inc. is not included in the NASDAQ 100 index
Is Matinas BioPharma Holdings, Inc. in the Dow Jones?
No, Matinas BioPharma Holdings, Inc. is not included in the Dow Jones index
When was Matinas BioPharma Holdings, Inc. last earnings report?
Matinas BioPharma Holdings, Inc.'s most recent earnings report was on August 13, 2025
When does Matinas BioPharma Holdings, Inc. report earnings?
The date for Matinas BioPharma Holdings, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MTNB Official Website www.matinasbiopharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1582554/000164117225004882/0001641172-25-004882-index.htm
- MTNB Profile on Yahoo Finance finance.yahoo.com/quote/MTNB
- MTNB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mtnb